OXBT ends global distribution deals, pulls Dermacyte sales focus to US
The attempt to sell Dermacyte globally failed in part because the international distributors simply didn’t buy enough of the product. Oxygen reached an agreement with Dermacyte Switzerland for exclusive rights to distribute Dermacyte in the European Union, Switzerland and Russia that called for the distributor to buy 40,000 units by the end of 2011. Boosting that purchase to 60,000 units would give the distributor the option to expand the agreement to South America.Oxygen reached a separate deal in 2011 with Mexican company Comercial Uni2 to buy 10,000 units of Dermacyte by the end of that year. Central America could be added to the agreement if purchase milestones were reached. But in a securities filing, Oxygen said both distributors breached the contracts by failing to buy enough Dermactye. No termination fees or payments were triggered by the action.





Independent sales consultants: Secrets behind success: Feisley said she holds
Come to "Personal Trainer,
Independent sales consultants: Secrets behind success: Feisley said she holds skin care classes daily, teaching ...
RT @: RT @: GREAT sales @ for the last weekend. Stock up on skin care, ornaments for next year & clothing @







